{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:20:02Z","timestamp":1787552402304,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,23]]},"DOI":"10.7759\/cureus.115052","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:37:11Z","timestamp":1787549831000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Serum Lipid Profile With Diabetic Retinopathy Severity in Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study From Eastern India"],"prefix":"10.7759","author":[{"given":"Lalhmingmawii","family":"C","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianus Deepak","family":"Lakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsala","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Tirkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.945245","article-title":"Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes","volume":"9","author":"Barrot J","year":"2022","unstructured":"Barrot J, Real J, Vlacho B, et al.. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Front Med (Lausanne). 2022, 9:945245. 10.3389\/fmed.2022.945245","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang W","year":"2018","unstructured":"Wang W, Lo AC. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018, 19:1816. 10.3390\/ijms19061816","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter?","volume":"61","author":"Sim\u00f3 R","year":"2018","unstructured":"Sim\u00f3 R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter?. Diabetologia. 2018, 61:1902-12. 10.1007\/s00125-018-4692-1","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo ZL","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, et al.. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021, 128:1580-91. 10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan GS","year":"2017","unstructured":"Tan GS, Cheung N, Sim\u00f3 R, Cheung GC, Wong TY. Diabetic macular oedema. Lancet Diabetes Endocrinol. 2017, 5:143-55. 10.1016\/S2213-8587(16)30052-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22","volume":"114","author":"Chew EY","year":"1996","unstructured":"Chew EY, Klein ML, Ferris FL 3rd, et al.. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol. 1996, 114:1079-84. 10.1001\/archopht.1996.01100140281004","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0793","article-title":"Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids","volume":"34","author":"Sasongko MB","year":"2011","unstructured":"Sasongko MB, Wong TY, Nguyen TT, Kawasaki R, Jenkins A, Shaw J, Wang JJ. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care. 2011, 34:474-9. 10.2337\/dc10-0793","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000499541","article-title":"Diabetic retinopathy in the context of patients with diabetes","volume":"62","author":"Sim\u00f3-Servat O","year":"2019","unstructured":"Sim\u00f3-Servat O, Hern\u00e1ndez C, Sim\u00f3 R. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res. 2019, 62:211-7. 10.1159\/000499541","journal-title":"Ophthalmic Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080593","article-title":"Factors associated with knowledge of diabetes in patients with type 2 diabetes using the diabetes knowledge test validated with Rasch analysis","volume":"8","author":"Fenwick EK","year":"2013","unstructured":"Fenwick EK, Xie J, Rees G, Finger RP, Lamoureux EL. Factors associated with knowledge of diabetes in patients with type 2 diabetes using the diabetes knowledge test validated with Rasch analysis. PLoS One. 2013, 8:e80593. 10.1371\/journal.pone.0080593","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.030","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie house classification: ETDRS report number 10","volume":"127","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"2020","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie house classification: ETDRS report number 10. Ophthalmology. 2020, 127:S99-119. 10.1016\/j.ophtha.2020.01.030","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001, 285:2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.51997","article-title":"Risk factors for diabetic retinopathy among Jordanian diabetics","volume":"15","author":"Al-Bdour MD","year":"2008","unstructured":"Al-Bdour MD, Al-Till MI, Abu Samra KM. Risk factors for diabetic retinopathy among Jordanian diabetics. Middle East Afr J Ophthalmol. 2008, 15:77-80. 10.4103\/0974-9233.51997","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02321-2","article-title":"Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Li Z","year":"2023","unstructured":"Li Z, Yuan Y, Qi Q, Wang Q, Feng L. Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Syst Rev. 2023, 12:148. 10.1186\/s13643-023-02321-2","journal-title":"Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.620045","article-title":"Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives","volume":"12","author":"Rao H","year":"2021","unstructured":"Rao H, Jalali JA, Johnston TP, Koulen P. Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives. Front Endocrinol (Lausanne). 2021, 12:620045. 10.3389\/fendo.2021.620045","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012283","article-title":"Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis","volume":"97","author":"Zhou Y","year":"2018","unstructured":"Zhou Y, Wang C, Shi K, Yin X. Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine (Baltimore). 2018, 97:e12283. 10.1097\/MD.0000000000012283","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03022-3","article-title":"Associations between lipid abnormalities and diabetic retinopathy across a large United States national database","volume":"38","author":"Jeong H","year":"2024","unstructured":"Jeong H, Maatouk CM, Russell MW, Singh RP. Associations between lipid abnormalities and diabetic retinopathy across a large United States national database. Eye (Lond). 2024, 38:1870-5. 10.1038\/s41433-024-03022-3","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.TR120000981","article-title":"Lipid metabolism dysregulation in diabetic retinopathy","volume":"62","author":"Busik JV","year":"2021","unstructured":"Busik JV. Lipid metabolism dysregulation in diabetic retinopathy. J Lipid Res. 2021, 62:100017. 10.1194\/jlr.TR120000981","journal-title":"J Lipid Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.51329\/mehdiophthal1492","article-title":"Fenofibrate and diabetic retinopathy","volume":"13","author":"Karti O","year":"2024","unstructured":"Karti O, Saatci AO. Fenofibrate and diabetic retinopathy. Med Hypothesis Discov Innov Ophthalmol. 2024, 13:35-43. 10.51329\/mehdiophthal1492","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14377","article-title":"Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review","volume":"98","author":"Elkjaer AS","year":"2020","unstructured":"Elkjaer AS, Lynge SK, Grauslund J. Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review. Acta Ophthalmol. 2020, 98:329-36. 10.1111\/aos.14377","journal-title":"Acta Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech A","year":"2007","unstructured":"Keech A, Mitchell P, Summanen PA, et al.. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007, 370:1687-97. 10.1016\/S0140-6736(07)61607-9","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Friedewald WT","year":"2010","unstructured":"Friedewald WT, Buse JB, Bigger JT. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010, 363:233-44. 10.1056\/NEJMoa1001288","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523405-association-of-serum-lipid-profile-with-diabetic-retinopathy-severity-in-adults-with-type-2-diabetes-mellitus-a-cross-sectional-study-from-eastern-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:37:12Z","timestamp":1787549832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523405-association-of-serum-lipid-profile-with-diabetic-retinopathy-severity-in-adults-with-type-2-diabetes-mellitus-a-cross-sectional-study-from-eastern-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.115052","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}